Literature DB >> 2489040

Cellular selection leads to age-dependent and reversible down-regulation of transgenic immunoglobulin light chain genes.

S Pettersson1, M J Sharpe, D R Gilmore, M A Surani, M S Neuberger.   

Abstract

Analysis of immunoglobulin expression in mice transgenic for either a kappa light chain (driven by the kappa enhancer) or lambda light chain (driven by the IgH enhancer) revealed that the transgenic light chains are expressed by the majority of B lymphocytes in the neonatal mice. However, the proportion of B cells that express the transgenes at a detectable level decreases rapidly with age, with a concomitant increase in cells expressing rearrangements of one of the endogenous light chain loci. This appears to be the result of cellular selection. The down-regulation of transgene expression is not due to an irreversible mechanism as incubation of adult splenic lymphocytes with bacterial lipopolysaccharide leads to a rapid increase in the expression of the transgenic light chain on the B cell surface. In mice carrying the lambda transgene (but not in mice carrying the kappa transgene) the change with age in the pattern of transgene expression is accompanied by a shift towards B cells that do not express surface IgD. This shift towards IgM+/IgDlow B cells is also observed in mice transgenic for a chloramphenicol acetyltransferase gene linked to the IgH enhancer. This suggests that the down-regulation of IgD may either be due to the expression of a transgene that impairs B cell development or, alternatively, could be associated with the molecular events responsible for the down-regulation of IgH enhancer activity. The results also draw attention to the contribution of cellular selection in determining the pattern of expression of immunoglobulin transgenes and emphasize the importance of in vivo analysis of neonatal as well as adult transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2489040     DOI: 10.1093/intimm/1.5.509

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation.

Authors:  B Goyenechea; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

3.  Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy.

Authors:  F Ruberti; S Capsoni; A Comparini; E Di Daniel; J Franzot; S Gonfloni; G Rossi; N Berardi; A Cattaneo
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

4.  A T cell controlled molecular pathway regulating the IgH locus: CD40-mediated activation of the IgH 3' enhancer.

Authors:  P A Grant; T Andersson; M F Neurath; V Arulampalam; A Bauch; R Müller; M Reth; S Pettersson
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

5.  Identification of Ets-like lymphoid specific elements within the immunoglobulin heavy chain 3' enhancer.

Authors:  P A Grant; V Arulampalam; L Ahrlund-Richter; S Pettersson
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

6.  IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function.

Authors:  P A Grant; C B Thompson; S Pettersson
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

7.  Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes.

Authors:  M J Sharpe; C Milstein; J M Jarvis; M S Neuberger
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.